Yamamoto H - Search Results

1

Receptor for advanced glycation end products expressed on alveolar epithelial cells is the main target for hyperoxia-induced lung injury.

Ota C, Ishizawa K, Yamada M, Tando Y, He M, Takahashi T, Yamaya M, Yamamoto Y, Yamamoto H, Kure S, Kubo H. Ota C, et al. Among authors: yamamoto y, yamamoto h. Respir Investig. 2016 Mar;54(2):98-108. doi: 10.1016/j.resinv.2015.08.009. Epub 2015 Oct 17. Respir Investig. 2016. PMID: 26879479

2

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells.

He M, Kubo H, Morimoto K, Fujino N, Suzuki T, Takahasi T, Yamada M, Yamaya M, Maekawa T, Yamamoto Y, Yamamoto H. He M, et al. Among authors: yamamoto y, yamamoto h. EMBO Rep. 2011 Apr;12(4):358-64. doi: 10.1038/embor.2011.28. Epub 2011 Mar 11. EMBO Rep. 2011. PMID: 21399623 Free PMC article.

3

Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury.

Yamamoto Y, Yamamoto H. Yamamoto Y, et al. Among authors: yamamoto h. Kidney Int. 2012 Oct;82(7):733-5. doi: 10.1038/ki.2012.163. Kidney Int. 2012. PMID: 22975994 Free article.

4

Receptor for advanced glycation end-products-mediated inflammation and diabetic vascular complications.

Yamamoto Y, Yamamoto H. Yamamoto Y, et al. Among authors: yamamoto h. J Diabetes Investig. 2011 Jun 5;2(3):155-7. doi: 10.1111/j.2040-1124.2011.00125.x. J Diabetes Investig. 2011. PMID: 24843476 Free PMC article. No abstract available.

5

Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications.

Yamamoto Y, Yamamoto H. Yamamoto Y, et al. Among authors: yamamoto h. J Diabetes Investig. 2012 Mar 28;3(2):107-14. doi: 10.1111/j.2040-1124.2011.00191.x. J Diabetes Investig. 2012. PMID: 24843553 Free PMC article. Review.

6

Evolution and diabetic vasculopathy.

Yamamoto H, Yamamoto Y. Yamamoto H, et al. Among authors: yamamoto y. J Diabetes Investig. 2022 Jul;13(7):1111-1113. doi: 10.1111/jdi.13843. Epub 2022 Jun 9. J Diabetes Investig. 2022. PMID: 35598317 Free PMC article.

7

Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma.

Kobayashi S, Kubo H, Suzuki T, Ishizawa K, Yamada M, He M, Yamamoto Y, Yamamoto H, Sasano H, Sasaki H, Suzuki S. Kobayashi S, et al. Among authors: yamamoto y, yamamoto h. Am J Respir Crit Care Med. 2007 Jan 15;175(2):184-9. doi: 10.1164/rccm.200602-212OC. Epub 2006 Oct 5. Am J Respir Crit Care Med. 2007. PMID: 17023736

8

The role of the receptor for advanced glycation end-products in lung fibrosis.

He M, Kubo H, Ishizawa K, Hegab AE, Yamamoto Y, Yamamoto H, Yamaya M. He M, et al. Among authors: yamamoto y, yamamoto h. Am J Physiol Lung Cell Mol Physiol. 2007 Dec;293(6):L1427-36. doi: 10.1152/ajplung.00075.2007. Epub 2007 Oct 19. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 17951314 Free article.

9

Septic shock is associated with receptor for advanced glycation end products ligation of LPS.

Yamamoto Y, Harashima A, Saito H, Tsuneyama K, Munesue S, Motoyoshi S, Han D, Watanabe T, Asano M, Takasawa S, Okamoto H, Shimura S, Karasawa T, Yonekura H, Yamamoto H. Yamamoto Y, et al. Among authors: yamamoto h. J Immunol. 2011 Mar 1;186(5):3248-57. doi: 10.4049/jimmunol.1002253. Epub 2011 Jan 26. J Immunol. 2011. PMID: 21270403

10

[AGE-RAGE system in diabetic vascular complications].

Yamamoto Y, Yamamoto H. Yamamoto Y, et al. Among authors: yamamoto h. Nihon Rinsho. 2010 Nov;68 Suppl 9:39-44. Nihon Rinsho. 2010. PMID: 21661142 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,258 results

Search Page

Filters